Facilitating European Clinical Research

ECRIN is a public, non-profit organisation that links scientific partners and networks across Europe
to facilitate multinational clinical research. We provide sponsors and investigators with advice,
management services and tools to overcome hurdles to multinational trials and enhance collaboration.

Our Work

We provide our 12 member and observer countries with diverse trial support services
and contribute to 'infrastructure development' projects with additional European and international partners.

ECRIN in Numbers

Member & Observer Countries

Million citizens represented

Trials in ECRIN portfolio

Average # of countries per trial

Events

Date:

EOSC is launching a series of webinars to share the work and notable results of the project. Join in for one or more:

  • EOSC business model recommendations, 15 Sep 2020, 02:00 PM (GMT+2 - Amsterdam, Berlin, Vienna, Rome) 
    Session details | Register now
  • Integrating services into EOSC through EOSC-hub, 29 Sep 2020, 02:00 PM (GMT+2 - Amsterdam, Berlin, Vienna, Rome)
    Session details | Register now
  • EOSC-hub Technical Architecture, 13 Oct 2020, 02:00 PM (GMT+2 - Amsterdam, Berlin, Vienna, Rome)
    Session details | Register now
  • EOSC Portal orders - The user and provider perspectives, 27 Oct 2020, 02:00 PM (GMT+2 - Amsterdam, Berlin, Vienna, Rome)
    Session details | Register now
  • Using compute services in EOSC: Experiences and advices from EOSC-hub, 10 Nov 2020, 02:00 PM (GMT+2 - Amsterdam, Berlin, Vienna, Rome)
    Session details | Register now
Date:

The 2nd ESFRI RI-EOSC Workshop "Research Infrastructures shaping EOSC" initially planned on the same dates in Greece has gone digital. 

The main objective of the workshop is to bring together stakeholders from ESFRI, ESFRI RI and EOSC to develop a better understand of EOSC concept and its value for users. 

The plenary sessions are open while the breakout sessions will be limited to one person per organisation. 

For more information visit the ESFRI event page

Date:

Active engagement of conference participants is expected to discuss challenges and identify solutions on what could be done to optimise children’s access to new medicines:

  1. What data sources and digital technologies could bring to paediatric development on top of the use of extrapolation?
  2. How to best define children unmet medical needs?
  3. How to optimise the PIP process and regulatory approval

The conference will also explore what drug development means for Paediatricians, and in particular during COVID-19 pandemic.

Full Programme

For more details on conference, please visit the website